Insider Transactions in Q1 2023 at Protara Therapeutics, Inc. (TARA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 19
2023
|
Jathin Bandari Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,700
+34.59%
|
-
|
|
Jan 19
2023
|
Jacqueline Zummo Chf Scientific Operations Off |
BUY
Grant, award, or other acquisition
|
Direct |
19,900
+17.87%
|
-
|
|
Jan 19
2023
|
Hannah Fry VP, Controller |
BUY
Grant, award, or other acquisition
|
Direct |
5,900
+15.11%
|
-
|
|
Jan 19
2023
|
Jesse Shefferman CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
51,300
+5.29%
|
-
|
|
Jan 10
2023
|
Jathin Bandari Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,876
-9.23%
|
$5,628
$3.0 P/Share
|
|
Jan 10
2023
|
Jesse Shefferman CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,855
-0.67%
|
$17,565
$3.0 P/Share
|
|
Jan 10
2023
|
Jacqueline Zummo Chf Scientific Operations Off |
SELL
Payment of exercise price or tax liability
|
Direct |
5,225
-6.8%
|
$15,675
$3.0 P/Share
|
|
Jan 03
2023
|
Hannah Fry VP, Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
361
-1.31%
|
$722
$2.8 P/Share
|
|
Jan 03
2023
|
Jesse Shefferman CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,604
-0.75%
|
$13,208
$2.8 P/Share
|
|
Jan 03
2023
|
Jacqueline Zummo Chf Scientific Operations Off |
SELL
Payment of exercise price or tax liability
|
Direct |
2,159
-2.73%
|
$4,318
$2.8 P/Share
|